Regenerative medicine trailblazer 

Dietmar W. Hutmacher FTSE FAHMS

NF22 1024x512-14

Distinguished Professor Dietmar W.HutmacherFTSE FAHMS

Chair in Regenerative Medicine, Queensland University of Technology; Co-Director, Max Planck Queensland Centre for the Materials Science of Extracellular Matrices (QLD)

Distinguished Professor Dietmar W.Hutmacheris a global leader in scaffold-guided tissue regeneration (SGBR).Patient specific scaffolds are designed and manufactured by using a cutting-edge 3D printing technology platform, then implanted. The SGBR technology has repaired leg bones and badly damaged skulls and corrected congenital deformities. Approved by US and European authorities, more than 70,000 patients have been treated worldwide. 

After tissue regrows in the highly porous scaffold architecture, the scaffold material dissolves. Compared to titanium implants this is life-changing because implant removal is not required. This has transformed the treatment of large bone defects, especially for skull defects and related correction surgeries of babies and children. 

Dietmar’s career and work combines academia and industry. His research has led to six spinoff companies. Recently, Dietmar has pioneered ways to integrate tissue engineering technology into cancer research.